Literature DB >> 12646246

Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation.

A L Carey1, B Lamont, S Andrikopoulos, I Koukoulas, J Proietto, M A Febbraio.   

Abstract

IL-6 expression in skeletal muscle is stimulated by contractions. We sought to examine whether hyperinsulinaemia increases IL-6 mRNA in skeletal muscle and whether any increase is modified in insulin resistant muscle. We hypothesized that intramuscular IL-6 mRNA would be increased in response to insulin, but such an affect would be unaffected by insulin resistance because the primary insulin sensitive signalling protein responsible for activating IL-6 functions normally in insulin resistant muscle. Transgenic rats over-expressing the gluconeogenic regulatory enzyme phosphoenolpyruvate carboxykinase (PEPCK) were studied. White gastrocnemius muscle samples were obtained under hyperinsulinaemic, euglycaemic clamp (4 mU kg(-1)min(-1) insulin, plasma glucose concentration 4-6 mmol L(-1)) and basal conditions in both PEPCK (basal n=4; insulin n=5) and wild-type (CON) (basal n=5; insulin n=4) rats, which were previously injected with a bolus of 2-[1-14C]deoxyglucose (2-DG) into the carotid artery. Muscle samples were assayed for 2-DG uptake and IL-6 mRNA. No differences in 2-DG uptake or IL-6 mRNA were observed when comparing groups under basal conditions. Under clamp conditions, 2-DG uptake was lower (P<0.05) in PEPCK compared with CON. Insulin stimulation in CON did not change IL-6 mRNA compared with basal levels. In contrast, there was an approximately 8-fold increase (P<0.05) in IL-6 mRNA in insulin-stimulated PEPCK compared with CON basal levels. Insulin stimulation increases IL-6 gene expression in insulin resistant, but not healthy, skeletal muscle, suggesting that IL-6 expression in skeletal muscle is sensitive to changes in insulin in circumstances of insulin resistance. It is likely that the differences observed when comparing healthy with insulin resistant muscle are due to the differential activation of insulin sensitive signalling proteins responsible for activating IL-6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646246     DOI: 10.1016/s0006-291x(03)00267-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

2.  Myokine Expression in Muscle and Myotubes in Response to Exercise Stimulation.

Authors:  Jeffrey D Covington; Charmaine S Tam; Sudip Bajpeyi; Jose E Galgani; Robert C Noland; Steven R Smith; Leanne M Redman; Eric Ravussin
Journal:  Med Sci Sports Exerc       Date:  2016-03       Impact factor: 5.411

3.  Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells.

Authors:  T-F Tzeng; I-M Liu; J-T Cheng
Journal:  Diabetologia       Date:  2005-06-15       Impact factor: 10.122

Review 4.  Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes.

Authors:  Sine Haugaard Knudsen; Bente Klarlund Pedersen
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

5.  Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.

Authors:  A L Carey; C R Bruce; M Sacchetti; M J Anderson; D B Olsen; B Saltin; J A Hawley; M A Febbraio
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

6.  Correlation between RAGE gene promoter methylation and diabetic retinal inflammation.

Authors:  Shifeng Kan; Jing Wu; Chengxi Sun; Jing Hao; Zhen Wu
Journal:  Exp Ther Med       Date:  2017-10-26       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.